Tumor, Solid Clinical Trials

63 clinical trials for Tumor, Solid across international registries, including 18 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Phase II Study of Intensity Modulated Radiotherapy in Dose Painting for Sinus Carcinomas After Endoscopic Surgery — RECRUITING · PHASE2
• An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors — RECRUITING · PHASE1
• Standardized Nutritional Management of Pediatric Patients With Solid Tumors — RECRUITING · NA
• TumorGlow Intraoperative Molecular Imaging (IMI) — RECRUITING · PHASE1
• Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor — RECRUITING · PHASE1
• Study of RGL-270 Single Drug and Combined With Adebelimab in Patients in Patients at High Risk of Recurrence After Radical Treatment of Malignant Solid Tumors — RECRUITING · PHASE1
• A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. — RECRUITING · PHASE1
• Immune Profiling for Cancer Immunotherapy Response — RECRUITING
• T Cell Receptor Gene-Engineered T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor — RECRUITING · PHASE1
• T Cell Receptor Gene-Engineered T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor — RECRUITING · PHASE1
• Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment — RECRUITING · PHASE1
• Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors — RECRUITING · PHASE1
• LEU01101: Safety and Preliminary Efficacy of LEU011 in Solid Tumours. — RECRUITING · PHASE1
• T Cell Receptor Gene-Engineered T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor — RECRUITING · PHASE1
• A Study of PARG Inhibitor XNW29016 in Patients With Advanced Solid Tumors Who Failed Standard Treatment — RECRUITING · PHASE1
• AD1208 in Subjects With Any Progressive, Locally Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents — RECRUITING · PHASE1
• Comparison of FDG and FAPI in Patients With Various Types of Cancer — RECRUITING · NA
• The HistoSonics Edison™ System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY) — ACTIVE_NOT_RECRUITING · NA
• A Study of NTX-1088, a Monoclonal Antibody Targeting the Poliovirus Receptor (PVR, CD155), as Monotherapy and Combined With Pembrolizumab — ACTIVE_NOT_RECRUITING · PHASE1
• Varian ProBeam Proton Therapy System Clinical Trial (Shandong) — COMPLETED · NA
• Varian ProBeam360° Proton Therapy System China Clinical Trial (Wuhan) — COMPLETED · NA
• The HistoSonics Investigational System for Treatment of Primary Solid Renal Tumors Using Histotripsy — COMPLETED · NA
• Clinical Study of BDB018: Monotherapy and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors — COMPLETED · PHASE1
• Durvalumab and Tremelimumab Combination in Somatically Hypermutated Recurrent Solid Tumors — COMPLETED · PHASE2
• BDB001-201: A Clinical Study of BDB001 in Patients With PD-(L)1 Refractory Solid Tumors — COMPLETED · PHASE2
• BDB001-102: Open Label Dose Escalation of BDB001 in Combination w Atezolizumab — COMPLETED · PHASE1
• BDB001-101: Clinical Study of BDB001 as a Mono-therapy or in Combination With Pembrolizumab — COMPLETED · PHASE1
• A Study of HMBD-002, a Monoclonal Antibody Targeting VISTA, as Monotherapy and Combined With Pembrolizumab, in Patients With Advanced Solid Tumors — COMPLETED · PHASE1
• Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients — OTHER
• Trial of Ulixertinib in Combination With Hydroxychloroquine in Patients With Advanced Gastrointestinal (GI) Malignancies — TERMINATED · PHASE2
• Autologous TLPO Vaccine Basket — TERMINATED · PHASE2
• Interest of Preoperative Arteriography to Identify the Adamkiewicz Artery Before Surgery for Basi-thoracic Neuroblastic Tumors — NOT_YET_RECRUITING
• NW-301 TCR-T in Patients With Advanced Solid Tumor — NOT_YET_RECRUITING · PHASE1
• First-in-Human Study of the SHP2 Inhibitor BBP-398 in Patients With Advanced Solid Tumors — TERMINATED · PHASE1
• Varian ProBeam Proton Therapy System China Clinical Trial (Hefei) — COMPLETED · NA
• Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1) — ACTIVE_NOT_RECRUITING · PHASE2
• A Study of Tumor Neoantigen-specific T Cells in the Treatment of Advanced Solid Tumors — OTHER · PHASE1
• A Study Investigating agenT-797 in Participants With Relapsed/Refractory Solid Tumors — COMPLETED · PHASE1
• 68Ga-FAPI-46 PET for Imaging of FAP Expressing Cancer — COMPLETED · PHASE2
• Varian ProBeam Proton Therapy System China Clinical Trial (Guangzhou) — COMPLETED · NA
• PET Imaging of 68Ga-NOTA-H006 in Malignancy — NOT_YET_RECRUITING · NA
• 18F-AlF-FAPi-04 PET/CT Imaging in Patients With Solid Tumor — OTHER · PHASE1
• A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents — OTHER · PHASE1
• Performance and Safety of Biology-Guided Radiotherapy Using the RefleXion Medical Radiotherapy System (BIOGUIDE-X) — COMPLETED · NA
• Real-time Tumor Localization and Guidance for Radiotherapy Using Ultrasound (US) and Magnetic Resonance (MR) — TERMINATED
• [18F]FPIA PET/CT Imaging in Patients With Solid Tumours — OTHER · PHASE2
• Tumor Rebiopsy in Children and Adolescents With Recurrent or Progressive Solid Malignancies — COMPLETED
• Biomarkers of Renal Cancer — OTHER

Refine this search